Tag Archives: Approved

oneM2M specifications approved by more than 190 ITU member countries as ITU standard to simplify IoT adoption

More than 190 ITU-T member countries have approved oneM2M specifications as ITU standard, simplifying the IoT ecosystem lifecycle by minimizing development, deployment, and maintenance costs. The ITU-T’s SG20 Internet of Things (IoT) and smart cities and communities (SC&C) approved oneM2M’s security specifications for IoT systems as part of the ITU-T Y.4500.3 series, making the entire… Read More »

Protein shakes approved for HCG diet

It can provide your body with the nutrition it needs while limiting the number of calories you consume without the need to snack between meals after one drink. This can easily be avoided in the HCG diet by reading the nutrition label. Simeons who maintain the view that if it is not given in the… Read More »

Coronavirus vaccine: Treatment approved for use by NHS – ‘Thousands of lives to be saved’

Coronavirus has killed more than 40,000 people in the UK, with the number continuing to rise. But, scientists have made a breakthrough in the search for a COVID-19 vaccine. The NHS has been backed to immediately use the dexamethasone steroid as a treatment for coronavirus. The drug has been revealed to lower the risk of… Read More »

Palforzia, If Approved For Peanut Allergy, May Widen Access To A Known Treatment : Shots – Health News – NPR

Enlarge this image Palforzia, a new drug to treat peanut allergies, is expected to get FDA approval. The main ingredient of the drug is peanut flour. Marco Livolsi/EyeEm/Getty Images hide caption toggle caption Marco Livolsi/EyeEm/Getty Images A panel of experts earlier this month recommended that the U.S. Food and Drug Administration approve a new drug… Read More »

Novartis slaps $2M-plus price tag on newly approved gene therapy Zolgensma—and cost watchdogs approve

Industry watchers have been speculating for months about just how high Novartis would price gene therapy Zolgensma on approval—and just how payers would cover it. And with the FDA’s green light, they now have an answer. The Swiss drugmaker will roll out the drug, a one-time treatment for pediatric patients less than 2 years of… Read More »